GO:0006583 melanin biosynthetic process from tyrosine: Pigment Synthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006583 describes the biochemical route that converts tyrosine into melanin, the main pigment responsible for skin, hair and eye color.
• The pathway is initiated by tyrosinase, a copper-dependent enzyme that hydroxylates tyrosine to L-DOPA and then oxidizes it to dopaquinone.
• Melanin is a heterogeneous biopolymer with photoprotective, antioxidant and metal-binding properties that influence skin homeostasis and retinal health.
• Dysregulation of melanin synthesis is linked to pigmentation disorders, melanoma biology and age-related macular degeneration.
• CRISPR knockout, point-mutation and knock-in models of TYR, TYRP1, DCT and related genes enable causal dissection of the pathway.
• GO:0006583 is a useful annotation target for functional genomics, pigmentation research and therapeutic screening.
Description
GO:0006583, melanin biosynthetic process from tyrosine, is a biological process ontology term that captures the enzymatic conversion of the amino acid tyrosine into melanin, the principal pigment in mammals and many other organisms. Melanin is not a single molecule but a family of heterogeneous biopolymers, including eumelanin and pheomelanin, that arise from a shared tyrosinase-dependent branch of tyrosine metabolism. The term is therefore central to understanding how organisms build pigment, how pigmentation is regulated, and how defects in this route contribute to disease. For researchers, GO:0006583 provides a precise annotation framework for interpreting transcriptomic, proteomic and genetic screens in pigment cells, melanoma models and retinal pigment epithelium. Because the pathway is enzymatically tractable and visually read out, it is also a powerful system for testing CRISPR-based causal hypotheses about gene function.
melanin biosynthetic process from tyrosine At A Glance
| GO ID | GO:0006583 |
|---|---|
| GO term | melanin biosynthetic process from tyrosine |
| Ontology | biological_process |
| Synonym | melanin anabolism from tyrosine; melanin formation from tyrosine; melanin synthesis from tyrosine |
| Major function | Enzymatic conversion of tyrosine into melanin pigments, including eumelanin and pheomelanin precursors |
| Key enzyme | Tyrosinase (TYR), a copper-dependent monooxygenase that catalyzes the rate-limiting steps |
| Subcellular location | Melanosomes, specialized lysosome-related organelles in pigment cells |
| Related processes | Melanosome transport, melanosome degradation, and pigmentation regulation |
| Representative organisms | Mammals, birds, reptiles, amphibians, fish and many microorganisms |
What Is GO:0006583?
In our own words, GO:0006583 refers to the set of chemical reactions and pathways that produce melanin starting from tyrosine. It includes the initial hydroxylation and oxidation steps catalyzed by tyrosinase, the subsequent non-enzymatic and enzymatic conversions that generate melanin precursors, and the polymerization reactions that yield mature melanin pigment. The term is narrower than general melanin metabolism because it specifies tyrosine as the starting compound, and it is distinct from melanosome transport or degradation, which are separate processes.
Why Is melanin biosynthetic process from tyrosine Important in Cell Biology?
GO:0006583 matters because melanin synthesis from tyrosine is a fundamental metabolic route that determines visible pigmentation and protects tissues from ultraviolet radiation and oxidative stress. It is also a clinically relevant pathway: alterations in melanin production are associated with pigmentation disorders, melanoma progression and retinal degeneration. Understanding this process at the molecular level supports the development of therapeutic and cosmetic strategies that modulate pigmentation.
• Melanin provides photoprotection by absorbing UV radiation and scavenging free radicals.
• The pathway is a model system for enzyme kinetics and copper-dependent catalysis.
• Pigmentation disorders such as albinism and vitiligo involve defects in melanin synthesis.
• Melanoma cells often retain or reactivate melanin biosynthetic activity, making it a diagnostic and therapeutic target.
• Retinal pigment epithelium melanin influences the progression of age-related macular degeneration.
• Melanin can bind drugs and chemicals, affecting pharmacokinetics and toxicity.
• Microbial melanin production from tyrosine has industrial and biotechnological relevance.
• CRISPR screens targeting GO:0006583 genes can reveal new regulators of pigmentation.
• The pathway is a testing ground for gene-editing therapies aimed at correcting pigmentation defects.
• Understanding melanin synthesis informs the design of skin-lightening and tanning agents.
What Happens During melanin biosynthetic process from tyrosine?
Tyrosine uptake and availability
In simple terms: The cell first needs to get tyrosine, the starting material for melanin.
Melanin synthesis begins with the availability of L-tyrosine, which can be taken up from the extracellular environment or synthesized intracellularly. In melanocytes, tyrosine is transported into melanosomes, the specialized organelles where melanin is produced. The supply of tyrosine and the activity of transporters can influence the overall rate of melanin production.
Hydroxylation of tyrosine to L-DOPA
In simple terms: Tyrosinase adds an oxygen atom to tyrosine to make L-DOPA.
The first committed step is the hydroxylation of L-tyrosine to L-3,4-dihydroxyphenylalanine (L-DOPA), catalyzed by tyrosinase (TYR), a copper-containing enzyme. This reaction is rate-limiting and requires molecular oxygen and a copper cofactor. Mutations in TYR that impair this step cause oculocutaneous albinism type 1.
Oxidation of L-DOPA to dopaquinone
In simple terms: Tyrosinase then converts L-DOPA into a reactive intermediate called dopaquinone.
Tyrosinase further oxidizes L-DOPA to dopaquinone, a highly reactive ortho-quinone. Dopaquinone is a branch point: in the presence of cysteine or glutathione, it can be converted to pheomelanin precursors, while in their absence it undergoes intramolecular cyclization to form eumelanin precursors.
Eumelanin and pheomelanin branch pathways
In simple terms: Dopaquinone can go down two different roads, leading to brown-black eumelanin or yellow-red pheomelanin.
The eumelanin branch involves cyclization of dopaquinone to leukodopachrome, followed by oxidation to dopachrome and further conversion by dopachrome tautomerase (DCT) to 5,6-dihydroxyindole-2-carboxylic acid (DHICA), which is then oxidized by tyrosinase-related protein 1 (TYRP1). The pheomelanin branch depends on the availability of cysteine, which conjugates with dopaquinone to form cysteinyldopa and ultimately pheomelanin. The ratio of eumelanin to pheomelanin determines the color and photoprotective properties of the pigment.
Polymerization and deposition in melanosomes
In simple terms: The precursor molecules link together to form melanin granules inside melanosomes.
The final stage involves oxidative polymerization of indole and quinone intermediates into insoluble melanin polymers, which are deposited on a protein matrix within melanosomes. Melanosomes then mature and are transported to keratinocytes, where they provide pigmentation and photoprotection. Melanosome degradation is a separate process that can release melanin or its intermediates.
Key Genes Involved in GO:0006583 melanin biosynthetic process from tyrosine
The following genes encode enzymes, transporters and regulatory proteins directly involved in or influencing the melanin biosynthetic process from tyrosine.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TYR | Rate-limiting enzyme that hydroxylates tyrosine and oxidizes L-DOPA | Primary target for albinism and pigmentation studies |
| TYRP1 | Stabilizes tyrosinase and catalyzes DHICA oxidation in eumelanin synthesis | Modifier of melanin content and melanoma phenotype |
| DCT | Dopachrome tautomerase that converts dopachrome to DHICA | Regulates eumelanin composition and antioxidant response |
| PMEL | Structural protein that forms the melanosome matrix for melanin deposition | Melanosome biogenesis and pigment granule formation |
| OCA2 | Transporter involved in melanosome pH and tyrosine transport | Associated with oculocutaneous albinism type 2 and pigmentation variation |
| SLC45A2 | Transporter affecting melanosome pH and tyrosinase activity | Linked to pigmentation diversity and albinism |
| MC1R | G-protein coupled receptor that signals to increase eumelanin synthesis | Key regulator of pigmentation and melanoma risk |
| MITF | Master transcription factor controlling melanocyte differentiation and pigment gene expression | Central regulator of the melanin biosynthetic program |
| SOX10 | Transcription factor required for melanocyte development and MITF expression | Melanocyte specification and disease modeling |
| PAX3 | Transcription factor involved in melanocyte lineage specification | Developmental regulation of pigmentation genes |
| WNT1 | Secreted ligand that promotes melanocyte differentiation via MITF | Signaling input to melanin synthesis |
| EDNRB | Endothelin receptor that supports melanocyte survival and pigmentation | Pigmentation disorders and melanoma biology |
| KIT | Receptor tyrosine kinase essential for melanocyte migration and survival | Piebaldism and melanoma models |
| GPR143 | G-protein coupled receptor involved in melanosome biogenesis | Ocular albinism and retinal pigmentation |
| BACE2 | Protease implicated in pigmentation regulation in melanocytes | Pigmentation modulation target |
| ATP7A | Copper transporter required for tyrosinase copper loading | Menkes disease and pigmentation defects |
| CBS | Enzyme contributing to cysteine metabolism and pheomelanin branch | Modulation of pheomelanin synthesis |
How Is melanin biosynthetic process from tyrosine Regulated?
The melanin biosynthetic process from tyrosine is regulated at multiple levels. Transcriptionally, the MITF master regulator controls the expression of TYR, TYRP1, DCT and other pigment genes in response to signaling through MC1R, KIT and WNT pathways. Post-translationally, tyrosinase activity is controlled by copper loading via ATP7A, by glycosylation and by pH within melanosomes. The ratio of eumelanin to pheomelanin is influenced by cysteine availability and by the activity of the pheomelanin branch. Additionally, melanin itself can interact with chemicals and drugs, which may feed back on cellular metabolism.
melanin biosynthetic process from tyrosine and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TYR | Oculocutaneous albinism type 1 | TYR knockout melanocyte cell line |
| OCA2 | Oculocutaneous albinism type 2 | OCA2 point-mutation knock-in in melanocytes |
| TYRP1 | Albinism and pigmentation variation | TYRP1 knockout or overexpression models |
| MC1R | Pigmentation diversity and melanoma risk | MC1R knock-in or knockout in melanoma cells |
| GPR143 | Ocular albinism and RPE pigmentation | GPR143 knockout in RPE cells |
Pigmentation disorders and albinism
Defects in genes encoding tyrosinase or its partners cause oculocutaneous albinism, characterized by reduced or absent melanin in skin, hair and eyes. Mutations in TYR, OCA2, TYRP1 and SLC45A2 are well-documented causes of different albinism subtypes. These conditions highlight the importance of GO:0006583 for normal development and photoprotection.
Melanoma and pigmentation biology
Melanoma cells frequently exhibit dysregulated melanin synthesis, and the pathway is a source of diagnostic markers and potential therapeutic targets. The expression of TYR, TYRP1 and DCT is often maintained in melanoma, and immune responses against these proteins are exploited in immunotherapy. Understanding the biosynthetic route from tyrosine helps interpret melanoma pigmentation heterogeneity.
Age-related macular degeneration and retinal pigment epithelium
Melanin in the retinal pigment epithelium (RPE) protects against oxidative stress and light damage, and its decline is associated with age-related macular degeneration (AMD). RPE melanin content and composition influence disease progression, making GO:0006583 relevant to retinal biology.
Drug and chemical interactions with melanin
Melanin can bind various chemicals and drugs, affecting their distribution and toxicity. This interaction is relevant for pharmacokinetics and for understanding side effects in pigmented tissues. The biosynthetic pathway from tyrosine determines the amount and type of melanin available for such binding.
From melanin biosynthetic process from tyrosine-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TYR loss abolish melanin synthesis? | TYR knockout melanocyte cell line |
| How does a specific TYR point mutation affect enzyme activity? | TYR point-mutation knock-in via CRISPR |
| Can a tagged TYR reveal melanosome localization? | TYR knock-in with fluorescent tag |
| Does overexpression of MITF increase pigmentation? | MITF overexpression in melanocytes |
| Which genes regulate pheomelanin versus eumelanin? | CRISPR library screening in pigment cells |
| How does RPE melanin affect oxidative stress? | GPR143 or TYR knockout in RPE models |
How to Study the melanin biosynthetic process from tyrosine Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Expression levels of pigment genes | Transcriptional profiling in melanocytes |
| Tyrosinase activity assay | Enzymatic conversion of tyrosine to DOPA | Functional validation of TYR variants |
| Mass spectrometry | Melanin intermediates and protein modifications | Metabolomic and proteomic analysis |
| Fluorescence microscopy | Melanosome localization and pigmentation | Imaging of tagged proteins |
| Electron microscopy | Melanosome ultrastructure | Melanosome maturation studies |
| CRISPR knockout screening | Gene essentiality for pigmentation | Discovery of novel regulators |
| Melanin quantification assay | Total melanin content | Phenotypic comparison of edited cells |
Transcriptomic profiling of pigment genes
RNA-seq can quantify the expression of TYR, TYRP1, DCT, MITF and other genes in the melanin biosynthetic pathway under different conditions. This approach helps identify transcriptional changes that correlate with pigmentation phenotypes.
Proteomic and enzymatic assays
Mass spectrometry-based proteomics and tyrosinase activity assays measure protein abundance and catalytic activity in melanocytes. These methods can detect post-translational modifications and copper loading status.
Imaging and melanin quantification
Fluorescence microscopy, electron microscopy and spectrophotometric melanin assays allow visualization and quantification of melanin granules in cells and tissues. These techniques are essential for confirming knockout or knock-in phenotypes.
CRISPR screening and functional genomics
Pooled CRISPR knockout or activation screens can identify novel regulators of melanin synthesis from tyrosine. Such screens are powerful for discovering genes that modify pigmentation.
How CRISPR Can Be Used to Study GO:0006583 melanin biosynthetic process from tyrosine
Knockout
CRISPR knockout of TYR, TYRP1 or DCT in melanocyte cell lines abolishes or reduces melanin production, providing a clean loss-of-function model to study GO:0006583. These models are useful for validating gene function and for screening compensatory pathways.
Point Mutation
Introducing disease-associated point mutations into TYR or OCA2 via CRISPR base editing or homology-directed repair allows precise modeling of albinism variants. Such models help distinguish loss-of-function from hypomorphic alleles.
Knock-in
Knock-in of fluorescent tags or epitope tags into endogenous pigment genes enables real-time tracking of protein localization and turnover in melanosomes. This approach is valuable for studying melanosome dynamics and transport.
Overexpression
CRISPR activation or transgenic overexpression of MITF, TYR or other pathway genes can boost melanin synthesis and reveal rate-limiting steps. Overexpression models are also used to test therapeutic modulation of pigmentation.
How EDITGENE Supports melanin biosynthetic process from tyrosine Research
Researchers studying melanin biosynthetic process from tyrosine-related genes often need to determine whether a candidate gene is causally involved in pigment production or merely correlated with it. EDITGENE provides a full suite of CRISPR-based cell model services to enable such causal experiments, from knockout to precise point mutations and tagged knock-ins.
Contact EDITGENE today to design your custom CRISPR model for melanin biosynthetic process from tyrosine research.
Frequently Asked Questions About melanin biosynthetic process from tyrosine
What is GO:0006583?
GO:0006583 is the Gene Ontology term for melanin biosynthetic process from tyrosine, describing the enzymatic conversion of tyrosine into melanin pigments.
What genes are involved in melanin biosynthetic process from tyrosine?
Key genes include TYR, TYRP1, DCT, OCA2, SLC45A2, MC1R and MITF, which encode enzymes, transporters and regulators of the pathway.
What is the first step in melanin synthesis from tyrosine?
The first step is the hydroxylation of tyrosine to L-DOPA by the enzyme tyrosinase.
How is melanin biosynthetic process from tyrosine regulated?
It is regulated transcriptionally by MITF and signaling pathways such as MC1R and KIT, and post-translationally by copper loading and pH.
What diseases are associated with defects in melanin synthesis?
Defects cause oculocutaneous albinism, pigmentation disorders, and are linked to melanoma and age-related macular degeneration.
What is the difference between eumelanin and pheomelanin?
Eumelanin is brown-black and produced via the dopachrome/DHICA branch, while pheomelanin is yellow-red and requires cysteine conjugation.
How can CRISPR be used to study melanin biosynthetic process from tyrosine?
CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of genes in the pathway.
What cell models are used for melanin research?
Melanocyte cell lines, melanoma cells and retinal pigment epithelium cells are commonly used, with CRISPR editing to create isogenic models.
Why is melanin important for skin?
Melanin protects skin from UV radiation and oxidative stress, and its synthesis is a key determinant of skin color.
Can melanin bind drugs?
Yes, melanin can interact with various chemicals and drugs, influencing their distribution and toxicity.
Conclusion
GO:0006583, melanin biosynthetic process from tyrosine, is a well-defined biological process that underpins pigmentation, photoprotection and several human diseases. The pathway is enzymatically driven by tyrosinase and its partners, and is regulated by a network of transcription factors and signaling inputs. CRISPR-based models are powerful tools for dissecting this pathway and for developing therapeutic strategies targeting pigmentation. Continued research into this process will advance our understanding of pigment biology and its clinical implications.
References
- 1. You Y et al.. 2025. Endogenous tyrosinase-catalyzed therapeutics.. Nat Commun 16(1):6463 PMID: 40651969
- 2. Riley PA. 1997. Melanin.. Int J Biochem Cell Biol 29(11):1235-9 PMID: 9451820
- 3. Solano F. 2020. Photoprotection and Skin Pigmentation: Melanin-Related Molecules and Some Other New Agents Obtained from Natural Sources.. Molecules 25(7) PMID: 32230973
- 4. Arai T et al.. 1972. Chromogenicity of Streptomyces.. Appl Microbiol 23(2):402-6 PMID: 4622831
- 5. Bao M et al.. 2025. Melanosome Transport and Processing in Skin Pigmentation: Mechanisms and Targets for Pigmentation Modulation.. Int J Mol Sci 26(17) PMID: 40943549
- 6. Borovanský J et al.. 2003. Melanosome degradation: fact or fiction.. Pigment Cell Res 16(3):280-6 PMID: 12753402
- 7. Kaufmann M et al.. 2024. RPE melanin and its influence on the progression of AMD.. Ageing Res Rev 99:102358 PMID: 38830546
- 8. Larsson BS. 1993. Interaction between chemicals and melanin.. Pigment Cell Res 6(3):127-33 PMID: 8234197
